Clinical Trials Browser

COVID-19, Liver Diseases, Liver Neoplasms

NCT04066153 2025-04-06

Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions

Completed

43 enrolled

Genitourinary

Heart Failure, Kidney Diseases, Liver Diseases, Lung Diseases, Neoplasms, Nervous System Diseases

NCT05233098 2025-03-06

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Completed

6 enrolled 15 charts

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT05053412 2024-08-02

HEPATIC

Completed

1,556 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT04627012 2024-03-06

Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma

Completed

600 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT05471596 2024-03-04

MWA

Completed

60 enrolled

Gastrointestinal

Liver Diseases, Liver Neoplasms

NCT02337673 2023-09-29

Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography

Completed

130 enrolled

GastrointestinalThoracic

Airway Obstruction, Hypoxia, Pulmonary Atelectasis, Liver Diseases, Lung Diseases, Pancreatic Diseases, Pleural Effusion, Pneumonia, Pneumothorax, Pulmonary Edema, Respiratory Distress Syndrome, Stomach Neoplasms

NCT01390194 2023-09-06

Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma

Completed

25 enrolled

Gastrointestinal

Hepatitis, Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Diseases

NCT04375670 2022-08-09

COVID19-FOIE National Observatory

Completed

1,132 enrolled

Gastrointestinal

COVID-19, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases

NCT02921828 2022-07-05

A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg

Completed

1,149 enrolled

GenitourinaryPlasma cell

Sleepiness, Arrhythmias, Cardiac, Confusion, Consciousness Disorders, Dizziness, Fatigue, Heart Failure, Hypersensitivity, Infections, Jaundice, Liver Diseases, Multiple Myeloma, Peripheral Nervous System Diseases, Thromboembolism, Tumor Lysis Syndrome, Lung Diseases, Interstitial, Acute Kidney Injury, Teratogenesis

NCT03405909 2021-03-02